Clathrin-mediated endocytosis is the major pathway by which cells internalize materials from the external environment. Dynamin, a large multidomain GTPase, is a key regulator of clathrin-mediated endocytosis. It assembles at the necks of invaginated clathrin-coated pits and, through GTP hydrolysis, catalyzes scission and release of clathrin-coated vesicles from the plasma membrane. Several small molecule inhibitors of dynamin's GTPase activity, such as Dynasore and Dyngo-4a, are currently available, although their specificity has been brought into question. Previous screens for these inhibitors measured dynamin's stimulated GTPase activity due to lack of sufficient sensitivity, hence the mechanisms by which they inhibit dynamin are uncertain. We report a highly sensitive fluorescence-based assay capable of detecting dynamin's basal GTPase activity under conditions compatible with high throughput screening. Utilizing this optimized assay, we conducted a pilot screen of 8000 compounds and identified several "hits" that inhibit the basal GTPase activity of dynamin-1. Subsequent dose-response curves were used to validate the activity of these compounds. Interestingly, we found neither Dynasore nor Dyngo-4a inhibited dynamin's basal GTPase activity, although both inhibit assembly-stimulated GTPase activity. This assay provides the basis for a more extensive search for more potent and chemically desirable dynamin inhibitors.
Introduction
Dynamin is a large multidomain GTPase known for its role in catalyzing membrane fission in clathrin-mediated endocytosis (CME) [1] [2] [3] . It consists of five functional domains: an N-terminal GTPase domain (G domain); the middle domain and GTPase effector domains (GEDs), which together form the stalk of dynamin; a pleckstrin homology (PH) domain; and a C-terminal proline-and arginine-rich domain (PRD), which interacts with many SH3 domain-containing proteins [4] . Dynamin assembles at the necks of invaginated clathrin-coated pits and catalyzes scission and release of clathrin-coated vesicles from the plasma membrane. Dynamin is recruited to nascent coated pits in its unassembled state and also plays a regulatory role during the early stages of CME [5] [6] [7] .
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Most GTPase family members that function as regulatory proteins do so by switching between GTP-bound 'active' conformations and GDP-bound 'inactive' states. Their intrinsic GTP hydrolysis rates are slow, and rate-limited by the exchange of tightly-bound GDP for GTP. These two steps in the GTP hydrolytic cycle are regulated by GTPase activating proteins (GAPs) and GTP exchange factors (GEFs), respectively. In this regard, dynamin is an atypical GTPase as it has a low affinity for GTP (2-5 μM), a high rate of GDP dissociation (~60-90 s -1 ), and a comparatively robust and measurable basal rate of GTP hydrolysis (~1 min -1 at 37˚C) [8] . However, upon self-assembly, interactions between G domains can stimulate GTPase activity in trans [9] . In vivo, dynamin self-assembles into short helical structures that surround the necks of deeply invaginated coated pits. In vitro, dynamin assembles into long helical arrays around lipid nanotubes whereby its GTPase activity is stimulated > 100-fold [10] . Dynamin's GTPase activity can also be stimulated, albeit to a lesser extent, through interactions with divalent SH3 domain containing partners such as Grb2 [11, 12] or under low salt conditions that favor dynamin self-assembly [13] . Given its importance for clathrin-mediated endocytosis, coupled to the fact that it is one of the few enzymes known to be required for CME, small molecule inhibitors of dynamin's GTPase activity have been sought as potentially powerful tools for studying CME. Indeed, several chemical inhibitors of dynamin have been reported and are commercially available, including Dynasore [14, 15] and its structural derivative, Dyngo-4a [14, 15] . However, recent findings have brought into question the specificity of these compounds. For example, Dynasore and Dyngo-4a continue to inhibit endocytosis in triple dynamin-1, 2, and 3 knockout cells, thus revealing potential off-target effects [16] . These off-target effects on endocytosis may reflect their reported ability to perturb plasma membrane cholesterol levels [17] and destabilize actin filaments [16] . Recently, Dynasore was shown to impair VEGFR2 signaling in an endocytosis-independent manner [18] . Based on the clear evidence for dynamin-independent, offtarget effects of these compounds, there remains a need to develop more specific and robust dynamin inhibitors.
Previous screens for small molecule inhibitors of dynamin's GTPase activity were based on the detection of released phosphate using a malachite green colorimetric assay. However, this assay lacks sufficient sensitivity to detect dynamin's basal GTPase activity, especially when measured at room temperature and at the low concentrations of dynamin and GTP practically needed for the design of a high-throughput assay. To circumvent this, previous high throughput screens measured dynamin's stimulated GTPase activity either in the presence of GSTGrb2 [14, 15] or with sonicated phosphatidylserine (PS) liposomes at low salt [14, 15] . Dynasore, and by extension Dyngo-4a, was shown to be a noncompetitive inhibitor of dynamin's GTPase activity [14, 15] . Hence its mechanism of action, which remains unknown, may reflect indirect effects on dynamin assembly or aggregation.
Here we report the optimization of a new, highly sensitive, and robust HTS-compatible assay to detect the basal GTPase activity of dynamin and its validation in a preliminary screen of 8000 compounds.
Materials and methods

Dynamin expression, purification, and preparation
Dynamin-1 (Dyn1) was expressed in Sf9 (Spodoptera frugiperda, GIBCO-BRL, Gaithersburg, MD) insect cells and purified by affinity chromatography, as previously described [19] . Nucleotide-free protein aliquots were stored in assay buffer containing 20 mM HEPES, 150 mM KCl, 1 mM EDTA, 1 mM EGTA and 1 mM DTT at pH 7.4. The aliquots were flash frozen in liquid nitrogen and stored in -80˚C in 5% v/v glycerol. Prior to running assays, frozen aliquots of Dyn1 were thawed and centrifuged at 100,000 g for 15 minutes to remove any aggregates. Dyn1 concentration was determined by measuring its absorbance at 280 nm with a UV/Vis spectrophotometer (Beckman Coulter Inc.) using a molar absorptivity coefficient of 73,800 M -1 cm
Transcreener GDP fluorescence polarization assay
The Transcreener 1 GDP FP (BellBrook Labs) assay is an immune-competition assay based on a mouse monoclonal antibody that selectively binds Alexa633-conjugated GDP over GTP. The preformed Alexa633-GDP antibody complex is added at the end of the reaction, and the GDP generated displaces bound Alexa633 fluorescent tracer, resulting in a decrease in its far-red fluorescence polarization (FP). The assay detects GDP production with high sensitivity at low substrate concentrations and has been used to develop an HTS compatible assay for the enzymatic activity of ARFGAP [20] . Stocks of 5 mM GTP, 10x Stop & Detect Buffer B, 400 nM GDP Alexa633 Tracer, and 3100 μg/mL GDP antibody were purchased from BellBrook Labs (Madison, WI). Assays were performed in Corning 384-well plates at room temperature. All assays were conducted in the endpoint format, which measures total GDP production after 60 minutes of incubation at room temperature. The optimized reaction (total volume 15 μL) was initiated by adding 5 μL of GTP (3x stock of 30 μM, final concentration 10 μM) to wells containing 10 μL Dyn1 (1.5x stock, final concentration 50 or 100 nM). Reactions were terminated after 60 minutes with the addition of 5 μL of GDP detection mixture (4x stock of 8 nM GDP Alexa633 Tracer, 40 mM HEPES, 80 mM EDTA, 0.04% Brij and 34.4 μg/mL GDP antibody). The plates were incubated for another 60 minutes, allowing the GDP antibody-GDP binding to reach equilibrium. The plate was then read for fluorescence polarization in millipolarization units (mP) using an EnVision multi-modal microplate reader (PerkinElmer, Inc.). The mP values of the reaction-containing wells were subtracted from those containing no enzyme to obtain ΔmP values. To convert the polarization data to GDP released, a standard curve representing 0 to 100% GDP conversion from 10 μM GTP was generated. Using GraphPad Prism, the ΔmP values were fitted to the standard curve to obtain the total GDP production.
Mock screen
15 μL reactions with 50 nM Dyn1 were incubated for 60 minutes with 0.3 μL of 100% DMSO in the presence of 10 μM GTP. Reactions that lacked Dyn1 were included as positive controls for complete inhibition. The mock screen was run in accordance with the Transcreener GDP FP assay protocol.
8000-compound library screen
A screen was performed using the optimized Transcreener GDP FP assay on a diverse library subset of 8000 small molecule compounds, provided by the UT Southwestern HTS Core. For the HTS screen, the final concentration of Dyn1 in the reaction mixture was 50 nM. 0.3 μL of compound in 100% DMSO (final concentration 10 μM compound, 2% DMSO) was added to the Dyn1 and pre-incubated for 30 minutes. Controls for the screen included reactions that lacked enzyme (positive control for inhibition) and uninhibited reactions containing only DMSO (negative control for inhibition), which were dispensed in single columns in each plate. Solutions were dispensed using automated liquid handling devices.
Data analysis
The primary screen data were analyzed using Genedata Screener 1 software. The Z' factors for the mock screen and the 8000-compound pilot screen were calculated using the equation below:
where σ positive control is the standard deviation of the positive controls for inhibition, and σ sample or negative control is the standard deviation of the samples or negative controls for inhibition, respectively. μ positive control is the mean of the positive control for inhibition, and μ sample or negative control is the mean of the samples or neutral DMSO controls, respectively. The samples were normalized by a two-point correction method using the equation below:
Two point normalized values ¼ raw value sample À median total samples median positive controls À median total samples Â 100 ð2Þ
where median total samples is defined as the median of all library compound-containing reaction wells within the plate.
The two-point normalized activity values were adjusted using a correction factor to account for systematic errors within and across assay plates [21] . The correction factor of a well in a given plate is calculated using pattern detection algorithms that are proprietary to the Screener where robust STD is the standard deviation calculated using the median of the DMSO controls (negative control for inhibition). For the confirmation screen and dose response curves, the data were analyzed by normalizing the sample GDP released to the control GDP released using the following equation:
Malachite green assay
The lipid nanotube (NT)-stimulated malachite green assays were performed in 96-well plates at 37˚C. The final reaction consisted of 100 nM Dyn1, 25 μM GTP, and 300 μM lipid nanotubes. The assay and reagent preparations were performed according to our published protocol [22] . All general chemicals were purchased from Sigma-Aldrich (St. Louis, MO). Compounds tested in the malachite green assay were purchased from Chembridge and ChemDiv (both located in San Diego, CA).
Results
Optimization of a fluorescence polarization assay to detect basal GTPase activity of dynamin
Fluorescence polarization (FP) is a method that allows for rapid and quantitative analysis of diverse molecular interactions and enzyme activities [23] . Polarization measures the change in the molecular movement of the labeled species. It is the ratio of the difference between the vertical and horizontal components of the emitted light over their sum [20] . In recent years, FP has been successfully used in HTS of compound libraries to identify small molecule inhibitors of protein-protein interactions.
Bellbrook labs has developed an assay that detects GDP using a competitive FP immunoassay. The GDP antibody binds both GDP and the GDP-Alexa633 tracer with similar affinities. The GDP released upon hydrolysis of GTP by GTPases displaces the fluorescent tracer from the antibody, resulting in a decrease in polarization due to increased rotational mobility ( Fig  1A) . The antibody has 140-fold specificity for GDP versus GTP, which allows sensitive measurement of GDP in the presence of excess GTP. Nonetheless, given that the antibody used has a finite selectivity for GDP over GTP, it was necessary to determine the optimal concentration of the Alexa-GDP antibody conjugate needed for maximum mP measured in the presence of 10, 100 and 500 μM GTP, our initial substrate concentrations. For this purpose, the Alexa-GDP antibody conjugate was titrated into the reaction mixture containing GTP (10, 100 or 500 μM) and assay buffer. The data were fitted to a variable slope sigmoidal dose-response curve using GraphPad Prism (Fig 1B) . From the titration curves, we determined the optimal The GDP antibody was titrated to determine its optimal concentrations for 10, 100 and 500 μM GTP. Optimal antibody concentrations are represented by the highlighted points (n = 1, measured in triplicates). C) Standard curve representing the conversion of 0 to 100% GDP from 10 μM GTP. This curve was used to convert the fluorescence polarization data to GDP released (n = 1, measured in triplicates). Data are presented as mean ± SD.
https://doi.org/10.1371/journal.pone.0185639.g001 GDP antibody concentrations to be 8.6, 81.5 and 405.5 μg/mL for 10, 100 and 500 μM GTP, respectively (highlighted data points in Fig 1B) . These concentrations were chosen near signal saturation and represent a good compromise between sensitivity and maximal polarization value.
To convert ΔmP to μM GDP released, we generated a standard curve by titrating increasing concentrations of GDP in the presence of GTP to mimic reaction conditions. The assay accurately measures GTP hydrolysis in the range of 0.05% to 10% of the substrate converted ( Fig  1C) .
To determine the optimal conditions for high throughput screening, we measured ΔmP for increasing concentrations of Dyn1 (0.3 nM to 5000 nM) at three different concentrations of GTP (10, 100, and 500 μM) (Fig 2A) . These titrations established that 50 nM Dyn1, assayed in the presence of 10 μM GTP for 60 minutes, resulted in excellent signal-to-noise with high reproducibility. We further confirmed that, under these conditions, the basal rate of GTP hydrolysis by Dyn1 (~0.04 min -1 at 10 μM GTP) was linear for 60 min (Fig 2B) . These results are consistent with assays performed at room temperature and under low substrate concentrations. We chose 60 minutes to ensure that substrate consumption remained below 10%. Importantly, no signal was detected at any concentration of GTP when S45N mutant Dyn1, which is unable to bind GTP [24] , was used as a negative control (Fig 2C) . We further confirmed that under these conditions, GTPase activity is directly proportional to the concentration of Dyn1. Thus, there is no evidence of cooperativity and the assay measures the basal rate of GTP hydrolysis of unassembled Dyn1 (Fig 2D) .
Mock screen
We measured the robustness of the assay under our optimized HTS conditions to determine whether 'hits' could be identified with high confidence. mP values obtained from the DMSO containing reaction wells were compared to the control wells. (Fig 3A) . The average Z' factor for the mock screen, which was calculated to be 0.56, indicated that the assay was sufficiently robust for screening purposes. Importantly, the assay was insensitive to DMSO concentrations up to 3%.
Pilot screen, hit selection and validation
A pilot screen using an 8000-compound diversity subset of the chemical library at UT Southwestern was conducted using the optimized Transcreener GDP FP assay. The compounds were tested for their inhibitory effects on the Dyn1 GTPase activity at a concentration of 10 μM.
Intrinsically fluorescent compounds interfere with fluorescence polarization measurement; therefore, compound-containing wells with total fluorescence intensities greater than 3 times those of control wells were eliminated. After careful analysis of the data, we identified 42 compounds with a robust Z score greater than 3 as primary hits (Fig 3B) .
These compounds were re-tested in a confirmation screen at three different concentrations (1, 3, and 10 μM) to validate their inhibitory effects. The confirmation screen yielded 4 compounds chosen based on concentration-dependent inhibition and their commercial availability (Fig 4A and 4B) .
To confirm the inhibitory effects of the 4 compounds, we conducted 11-point dose response curves, with concentrations ranging from 1 nM to 100 μM (Fig 4C) . The IC 50 values of these compounds ranged from < 1 μM to > 50 μM. We focused on compound 24 which had an IC 50 of 0.58 μM.
Secondary assay and comparison with Dynasore and Dyngo-4a
Compound 24 was compared with the two commercially available dynamin inhibitors, Dynasore and Dyngo-4a, in a dose-response assay measuring inhibition of basal GTPase activity under high salt (150 mM KCl) conditions. The concentration of inhibitors ranged from 1 nM to 100 μM. As seen in Fig 5A , Dynasore and Dyngo-4a do not appear to inhibit basal GTPase activity even at high concentrations, in contrast to previous findings in which assays were performed under conditions that measure dynamin's stimulated, assembly-dependent GTPase activity [14, 15] . Therefore, to more closely parallel previous studies we tested both commercial inhibitors in comparison to compound 24 for their effects on dynamin's stimulated GTPase activity. Assays were performed in the presence of PI(4,5)P 2 -containing lipid nanotubes (NT), whose diameter (~20 nm) resembles the neck of an invaginated coated pit [10] , using the malachite green assay. Under these conditions (100 nM Dyn1, 300 μM lipid nanotubes, 25 μM GTP), both Dynasore and Dyngo-4a inhibited the NT-stimulated GTPase activity of Dyn1 with IC 50 values of 83.5 and 45.4 μM, respectively, as compared to compound 24, which exhibited an IC 50 of 6.4 μM in this assay (Fig 5B) .
Discussion
We have optimized a robust, high-throughput assay to measure the basal GTPase activity of unassembled Dyn1. This highly sensitive assay detects the release of low, nanomolar amounts of GDP and hence, accurately measures the intrinsic, basal rate of GTP hydrolysis, even at the low concentrations of dynamin and GTP necessary for HTS design and implementation. Previous high throughput screens using a less sensitive colorimetric malachite green assay to detect phosphate release were necessarily performed under conditions that stimulate dynamin's GTPase activity, i.e. in the presence of dimeric GST-Grb2, which presumably aggregates dynamin, or with sonicated PS liposomes in low salt.
Utilizing the Transcreener GDP FP assay, we conducted an 8000-compound pilot screen and identified several compounds that inhibit the basal GTPase activity of Dyn1. The most potent of these, compound 24, inhibited dynamin's basal and lipid nanotubule assembly-stimulated GTPase activities with IC 50 values of~0.6 μM and~6 μM, respectively. However, this scaffold, identified as a potential "PAINS' (Pan Assay Interference Compound) [25] is not ideally suited for further refinement. Hence, we await results from a larger-scale screen to identify a lead scaffold appropriate for further development and optimization.
Importantly, current commercially available dynamin inhibitors, Dynasore and Dyngo-4a, were also tested for their ability to inhibit dynamin's basal GTPase activity in the Transcreener assay format. Although both Dynasore and Dyngo-4a could inhibit the NT-stimulated GTPase activity of Dyn1, neither was able to inhibit basal GTPase activity in our hands. Moreover, the reported IC 50 values we measured for Dynasore and Dyngo-4a NT-stimulated GTPase activity performed at physiological salt concentrations using 100 nM dynamin were much higher than those reported for assays performed in the presence of sonicated PS liposomes, under low salt conditions with 20 nM dynamin (0.4 μM and 12 μM, respectively). Given the reported off-target effects of Dynasore and Dyngo-4a [16] [17] [18] and their uncertain mechanism of dynamin inhibition, a more robust and specific inhibitor of dynamin would be of immense value.
As with any assay, fluorescence polarization has its limitations. Compounds that are either auto-fluorescent, or affect the affinity of the anti-GDP antibody for the tracer may be misinterpreted as potential hits [20] . The hits must therefore be validated in secondary assays such as the malachite green assay and eventually for their ability to inhibit dynamin-dependent, clathrin-mediated endocytosis in intact cells.
Having validated our assay using an 8000-compound pilot screen, we are currently expanding our search for more desirable chemical scaffolds and lead compounds to be used to develop more robust, specific, and cell-permeable dynamin inhibitors. Confirmation screen and dose-response studies. A) Flowchart of high-throughput screening used to identify and validate the hits from the 8000-compound screen. The 42 preliminary hits were chosen based on their RZ score and lack of intrinsic fluorescence. These were further narrowed down to 4 compounds that were chosen based on their ability to inhibit the GTPase activity of Dyn1 in a dose-dependent manner and their commercial availability B) Chemical structures of the 4 compounds that were tested in dose-response studies. C) 11-point dose response curve of the 4 validated hits from the primary screen of 8000 compounds measured using 50 nM Dyn1 and 10 μM GTP (n = 1, measured in triplicates). Data are presented as mean ± SD.
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